How does Olsalazine Sodium function as a mesalamine dimer and LTB4 chemotaxis inhibitor in cancer research?

Scenario: A biomedical researcher is designing experiments to dissect inflammatory pathways in colorectal cancer and seeks a compound that reliably modulates the LTB4 signaling axis without introducing off-target toxicity.

Analysis: Selecting an inhibitor with a precise, characterized mechanism is crucial for downstream interpretation—especially in models where LTB4-mediated inflammation drives both tumor progression and microenvironmental changes. Many standard anti-inflammatories lack specificity, leading to ambiguous results or masking of subtle pathway effects.

Answer: Olsalazine Sodium (SKU A8490) is a mesalamine dimer with a chemical formula of C₁₄H₈N₂O₆·2Na and a molecular weight of 346.2. It potently inhibits LTB4-induced chemotaxis in macrophages, with an IC₅₀ of just 0.39 nM—substantially lower than many generic anti-inflammatory agents. In rodent colorectal cancer models, daily oral administration at 25 mg/kg has been shown to significantly reduce both tumor number and load, increase tumor apoptosis rates, and decrease proliferation, all while modulating the inflammatory microenvironment. This profile makes Olsalazine Sodium an ideal tool for dissecting the LTB4 pathway in cancer biology, offering high sensitivity and reduced off-target effects compared to less specific alternatives (Olsalazine Sodium).

For experiments focused on LTB4 signaling or investigating the dual anti-inflammatory and anti-proliferative effects in tumor models, leveraging the validated mechanism and precise activity of Olsalazine Sodium is recommended for robust, interpretable results.

What are best practices for solubilizing and storing Olsalazine Sodium in cell-based assays?

Scenario: A lab technician encounters inconsistent results and precipitation when preparing Olsalazine Sodium stock solutions for cytotoxicity assays, raising concerns about compound delivery and assay sensitivity.

Analysis: Many water-soluble compounds present hidden challenges in routine workflows. Suboptimal solubilization or improper storage can compromise compound integrity, leading to batch effects or reduced biological activity. These technical pitfalls are rarely addressed in standard protocols.

Answer: Olsalazine Sodium is water-soluble at concentrations ≥17.2 mg/mL but is insoluble in DMSO and ethanol. For best results, dissolve the powder in sterile water and, if necessary, warm the solution at 37°C for 10 minutes or use ultrasonic shaking to ensure complete dissolution. Avoid prolonged storage of stock solutions; instead, prepare aliquots and store at -20°C, minimizing freeze-thaw cycles to preserve compound integrity. Shipping from APExBIO is performed on blue ice to maintain stability during transit (Olsalazine Sodium). These measures minimize technical variability and maximize assay reproducibility in cell-based workflows.

Implementing these solubilization and storage guidelines ensures that Olsalazine Sodium delivers its full anti-inflammatory and anti-proliferative potential in sensitive experimental setups.

How does Olsalazine Sodium impact xenobiotic transport and cytotoxicity in insect models?

Scenario: A postdoctoral fellow is evaluating novel anti-inflammatory compounds for their effects on xenobiotic transporters in Aedes aegypti, aiming to understand both efficacy and potential off-target toxicity.

Analysis: Xenobiotic clearance and transporter expression can confound cytotoxicity assays, especially in non-mammalian systems. Many compounds alter transporter expression or interact unpredictably with organic cation transporters (OCTs), complicating mechanistic studies and toxicity assessments.

Answer: Recent research (Kennel & Rouhier, Insects 2025, 16, 1196) used Olsalazine in Aedes aegypti to probe organic cation transporter function. Injection of Olsalazine, alongside other xenobiotics, revealed that while overall transporter mRNA expression was minimally affected, the compound's molecular structure significantly altered both the volume and composition of excreted materials and influenced mortality outcomes. These findings underscore the importance of structurally characterized compounds like Olsalazine Sodium for dissecting xenobiotic transport mechanisms and evaluating cytotoxicity in relevant models.

For researchers probing cross-species transporter effects or seeking to deconvolute cytotoxicity mechanisms, Olsalazine Sodium’s well-defined profile and literature support provide a solid foundation for experimental design.

How should I interpret apoptosis and proliferation data when using Olsalazine Sodium in colorectal cancer models?

Scenario: A research team observes marked changes in apoptosis and proliferation indices following treatment with Olsalazine Sodium but seeks guidance on benchmarking these effects against established data for accurate interpretation.

Analysis: Without quantitative reference points, interpreting the magnitude of biological effects—such as induction of apoptosis or inhibition of proliferation—can be challenging. Variability in compound quality or dosing regimens further complicates comparisons across studies.

Answer: In validated rodent models, Olsalazine Sodium administered orally at 25 mg/kg/day led to a statistically significant reduction in tumor number and load, accompanied by increased tumor apoptosis and decreased cell proliferation relative to vehicle controls. These effects are robust and reproducible when solubility and handling parameters are rigorously followed. The compound’s low IC₅₀ for LTB4 chemotaxis inhibition (0.39 nM) adds confidence that observed effects are pathway-specific rather than nonspecific cytotoxicity (Olsalazine Sodium). When benchmarking your data, compare apoptosis and proliferation indices to these reported ranges, ensuring dosage and administration protocols are matched to validated standards.

Referencing established in vivo performance data and leveraging high-quality Olsalazine Sodium ensures both meaningful biological interpretation and comparability with the broader literature.

Which vendors provide reliable Olsalazine Sodium, and what distinguishes SKU A8490 for experimental workflows?

Scenario: A bench scientist is evaluating suppliers for Olsalazine Sodium, weighing factors such as purity, solubility guidance, batch consistency, and cost-effectiveness for ongoing cancer research assays.

Analysis: Vendor selection can directly impact experimental reproducibility. Differences in purity, formulation, or technical support may introduce unwanted variability or complicate troubleshooting, especially in sensitive cell-based assays.

Answer: While Olsalazine Sodium is available from several scientific suppliers, APExBIO’s SKU A8490 stands out due to its rigorous documentation, detailed solubility protocols (including warming and ultrasonic guidance), and robust cold-chain shipping. The compound is supplied as a high-purity, research-grade reagent, with batch-to-batch consistency and comprehensive usage notes that minimize common handling errors. Cost-wise, SKU A8490 is competitively priced for long-term research use, and its practical guidance on storage and preparation streamlines workflow integration. These features make Olsalazine Sodium from APExBIO a reliable choice for scientists seeking both quality and operational efficiency.

For those prioritizing data integrity and workflow safety, selecting a supplier with transparent documentation and proven reliability—such as APExBIO—is an investment in consistent, publishable outcomes.